Integer to showcase strategic investments at Heart Rhythm 2024

Integer Holdings will join medtech industry leaders around the world in exhibiting at Heart Rhythm 2024, a Heart Rhythm Society educational event and exhibition in Boston from May 16 – 19, 2024. HRS attendees are invited to visit Integer at booth #753 to learn more about the company’s comprehensive end-to-end solutions, designed to help customers accelerate time to market, strengthen innovation, simplify supply chain and confidently scale production across a globally competitive network of locations. Some examples include market-leading battery technology, finished leads and implantable pulse generators for cardiac applications. Integer is a leading manufacturer of access and complex catheter access solutions in electrophysiology, including guidewires, transseptal access, diagnostic and ablation technology platforms. Those attending HRS will discover how Integer’s recent strategic investments, particularly the acquisition of Pulse Technologies, are reshaping how Integer serves the world’s leading medical device OEMs and start-ups. Pulse Technologies, based in Quakertown, Pennsylvania, brings unmatched precision machining and patented technologies such as Hierarchical Surface Restructuring coatings to Integer’s portfolio. These innovations significantly enhance the performance and reliability of medical devices across cardiac rhythm management, neuromodulation, and cardiovascular applications. HSR enhances electrodes and microelectrode arrays using a proprietary ultra-short pulse laser-based process, supporting a range of applications.